Literature DB >> 18817889

Transpeptidation and reverse proteolysis and their consequences for immunity.

Celia R Berkers1, Annemieke de Jong, Huib Ovaa, Boris Rodenko.   

Abstract

Reverse proteolysis and transpeptidation lead to the generation of polypeptide sequences that cannot be inferred directly from genome sequences as they are post-translational phenomena. These phenomena have so far received little attention although the physiological consequences may reach far. The protease-mediated synthesis of several immunodominant MHC class I antigens was recently reported, underscoring its importance to immunity. Reverse proteolytic and transpeptidation mechanisms as well as conditions that favor successful protease-catalyzed synthetic events are discussed here.

Mesh:

Substances:

Year:  2008        PMID: 18817889     DOI: 10.1016/j.biocel.2008.08.036

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  21 in total

1.  Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Hugo D Meiring; Lennert Janssen; Jacques J Neefjes; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

2.  Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Jan A J Geenevasen; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

3.  Driving forces of proteasome-catalyzed peptide splicing in yeast and humans.

Authors:  Michele Mishto; Andrean Goede; Kathrin Textoris Taube; Christin Keller; Katharina Janek; Petra Henklein; Agathe Niewienda; Alexander Kloss; Sabrina Gohlke; Burkhardt Dahlmann; Cordula Enenkel; Peter Michael Kloetzel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

4.  N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids.

Authors:  Robert S Jansen; Ruben Addie; Remco Merkx; Alexander Fish; Sunny Mahakena; Onno B Bleijerveld; Maarten Altelaar; Lodewijk IJlst; Ronald J Wanders; P Borst; Koen van de Wetering
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

5.  How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.

Authors:  Yang Wang; Tomasz Sosinowski; Andrey Novikov; Frances Crawford; Janice White; Niyun Jin; Zikou Liu; Jinhao Zou; David Neau; Howard W Davidson; Maki Nakayama; William W Kwok; Laurent Gapin; Philippa Marrack; John W Kappler; Shaodong Dai
Journal:  Sci Immunol       Date:  2019-04-05

6.  The 20S proteasome splicing activity discovered by SpliceMet.

Authors:  Juliane Liepe; Michele Mishto; Kathrin Textoris-Taube; Katharina Janek; Christin Keller; Petra Henklein; Peter Michael Kloetzel; Alexey Zaikin
Journal:  PLoS Comput Biol       Date:  2010-06-24       Impact factor: 4.475

7.  The two-step biosynthesis of cyclic peptides from linear precursors in a member of the plant family Caryophyllaceae involves cyclization by a serine protease-like enzyme.

Authors:  Carla J S Barber; Pareshkumar T Pujara; Darwin W Reed; Shiela Chiwocha; Haixia Zhang; Patrick S Covello
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

8.  N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.

Authors:  Niyun Jin; Yang Wang; Frances Crawford; Janice White; Philippa Marrack; Shaodong Dai; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-09       Impact factor: 11.205

Review 9.  Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes.

Authors:  Brendan K Reed; John W Kappler
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

10.  Response: Commentary: An In Silico-In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients.

Authors:  Michele Mishto; Guillermo Rodriguez-Hernandez; Jacques Neefjes; Henning Urlaub; Juliane Liepe
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.